P20 Research Project 1 Contingency Management for the Treatment of Co-Occurring Alcohol and Drug Misuse
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- Biochemically verified alcohol and/or drug abstinence
研究概览
简要总结
Contingency management (CM) is a type of treatment used in the substance abuse field. Patients' behaviors are rewarded for adherence to a treatment plan. As an approach to treatment, contingency management emerged from the behavior therapy traditions in mental health. By most evaluations, contingency management procedures produce one of the largest effect sizes out of all mental health and educational interventions.
The purpose of this study is to perform a randomized, controlled trial to evaluate the ability of a culturally-tailored contingency management (CM) intervention to increase alcohol and drug abstinence among American Indian (AI) tribal members from two rural reservations in the Northwest.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Factorial
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Self-identify race as American Indian (AI)
- •Are seeking alcohol dependence and drug abuse treatment at a participating reservation
- •Are age 18 or older
- •Meet criteria of DSM-IV diagnosis of current alcohol dependence
- •Current drug misuse
- •Are not pregnant or planning to become pregnant for the duration of the study
- •Are English speaking
- •Have the ability to provide written informed consent
排除标准
- •Have significant risk of dangerous alcohol withdrawal, defined as a history of alcohol detoxification or seizure during the last 12 months AND expression of concern by the patient and/or healthcare provider
- •Meet criteria for DSM-IV diagnosis of drug dependence
- •Have significant risk of dangerous drug withdrawal and/or self-reported or medically documented severe withdrawal from drugs in the last 6 months
- •Have any medical or psychiatric condition, such as organic brain disorder, dementia, or psychotic disorder, that the Principal Investigator determines would compromise safe study participation
- •Are receiving drugs under the direction of a physician for pain management or another medical condition for which drug abstinence is contraindicated
研究组 & 干预措施
CM for alcohol
CM for alcohol
干预措施: CM for Alcohol (Behavioral)
CM for drugs
CM for drugs
干预措施: CM for drugs (Behavioral)
CM for both substances
CM for both substances
干预措施: CM for both substances (Behavioral)
Non-Contingent group
No CM for either substance, the Non-Contingent (NC) group
干预措施: Non-Contingent group (Behavioral)
结局指标
主要结局
Biochemically verified alcohol and/or drug abstinence
时间窗: 24 weeks
At every study visit, urine samples will be collected and analyzed for ethyl glucuronide and drugs. This helps assess Contingency Management as a treatment for alcohol and/or drug dependence.
次要结局
- Self- reported data on health behaviors(24 weeks)
- Self- reported data on alcohol and drug use(24 weeks)
- Other substance use(24 weeks)
研究者
Michael McDonell
Associate Director & Associate Professor
Washington State University